Nektar Therapeutics CEO Howard Robin recently sold 423 shares of NKTR stock on February 18th for $73.00 per share, reducing his stake by 0.56%. Following this transaction, Robin now owns 75,489 shares valued at approximately $5.51 million. The stock is trading near its 12-month high of $74.89, with a market capitalization of $1.50 billion.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Howard Robin Sells 423 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
Nektar Therapeutics CEO Howard Robin recently sold 423 shares of NKTR stock on February 18th for $73.00 per share, reducing his stake by 0.56%. Following this transaction, Robin now owns 75,489 shares valued at approximately $5.51 million. The stock is trading near its 12-month high of $74.89, with a market capitalization of $1.50 billion.